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Background: Array comparative genomic hybridization (CGH) has been repeatedly shown to be a successful tool
for the identification of genomic variations in a clinical population. During the last decade, the implementation of
array CGH has resulted in the identification of new causative submicroscopic chromosome imbalances and copy
number variations (CNVs) in neuropsychiatric (neurobehavioral) diseases. Currently, array-CGH-based technologies
have become an integral part of molecular diagnosis and research in individuals with neuropsychiatric disorders
and children with intellectual disability (mental retardation) and congenital anomalies. Here, we introduce the
Russian cohort of children with intellectual disability, autism, epilepsy and congenital anomalies analyzed by BAC
array CGH and a novel bioinformatic strategy.
Results: Among 54 individuals highly selected according to clinical criteria and molecular and cytogenetic data
(from 2426 patients evaluated cytogenetically and molecularly between November 2007 and May 2012),
chromosomal imbalances were detected in 26 individuals (48%). In two patients (4%), a previously undescribed
condition was observed. The latter has been designated as meiotic (constitutional) genomic instability resulted in
multiple submicroscopic rearrangements (including CNVs). Using bioinformatic strategy, we were able to identify
clinically relevant CNVs in 15 individuals (28%). Selected cases were confirmed by molecular cytogenetic and
molecular genetic methods. Eight out of 26 chromosomal imbalances (31%) have not been previously reported.
Among them, three cases were co-occurrence of subtle chromosome 9 and 21 deletions.
Conclusions: We conducted an array CGH study of Russian patients suffering from intellectual disability, autism,
epilepsy and congenital anomalies. In total, phenotypic manifestations of clinically relevant genomic variations were
found to result from genomic rearrangements affecting 1247 disease-causing and pathway-involved genes.
Obviously, a significantly lesser part of them are true candidates for intellectual disability, autism or epilepsy. The
success of our preliminary array CGH and bioinformatic study allows us to expand the cohort. According to the
available literature, this is the first comprehensive array CGH evaluation of a Russian cohort of children with
neuropsychiatric disorders and congenital anomalies.
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Chromosomal imbalances and copy number variations
(CNVs) are probably the most common genetic causes of
intellectual disability (mental retardation) and congenital
anomalies. Genome variations involving chromosomal and
subchromosomal loci are frequently detected in a wide
spectrum of neuropsychiatric disorders. Indeed, these
patients seem to need in an evaluation by array compara-
tive genomic hybridization (CGH) or molecular karyotyp-
ing. The latter is repeatedly shown to be a powerful tool for
the identification of genomic variations (submicroscopic
chromosomal imbalances and CNVs) in a clinical popula-
tion. Moreover, to ensure an adequate diagnostic yield
(i.e. >10-15%), molecular diagnosis of constitutional
chromosomal and subchromosomal imbalances is recom-
mended to be performed by molecular karyotyping or
related array-CGH-based technologies, which has become
an important genetic test for patients suffering from intel-
lectual disability (neuropsychiatric diseases) and congeni-
tal anomalies. Whole-genome scanning technologies are
unique for detecting losses or gains of genomic material
and are consistently used for studying genetic causes of
postnatal morbidity (i.e. dysmorphology, malformations,
developmental delay, intellectual disability, autism, epi-
lepsy, and schizophrenia) providing for the delineation of
the molecular mechanisms and causative genes [1-10].
Here, we present the first Russian experience of an
array CGH application to a clinical population. The co-
hort included 54 children with intellectual disability, aut-
ism, epilepsy and congenital anomalies highly selected
from 2426 patients according to clinical criteria and mo-
lecular and cytogenetic data.
Results
Fifty four members of the Russian cohort of children with
intellectual disability, autism, epilepsy and congenital
anomalies were studied by BAC array CGH with the reso-
lution of 0.3-1 Mb. Some examples of array CGH gra-
phical overviews are shown in Figure 1. Details of the
cohort (array CGH results and patients) are summarized
in Table 1. Figure 2 overviews the incidence of genomic
imbalances in the cohort according to their type and to
the diagnosing feasibility or, in other words, the difference
between cytogenetically visible (patients re-evaluated by
cytogenetic analysis after array CGH) and cytogenetically
invisible chromosome aberrations. CNVs were evaluated
by a bioinformatic approach towards the CNV/gene prio-
ritization followed by genotype-phenotype correlations.
Selected cases were confirmed by molecular cytogenetic
and molecular genetic methods (Table 1).
Chromosomal imbalances
Constitutive chromosomal imbalances were detected in 26
individuals (including case #1 exhibiting three presumablyunrelated chromosome abnormalities). Chromosomal
imbalances (including multiple chromosome abnormal-
ities) observed in cases #1, #8, #11, #11, #12, #18, #26, #40,
and #43 were found to be unique to this cohort (Table 1).
Among them, we found a recurrent chromosome abnor-
mality specific to the Russian cohort of children with intel-
lectual disability, autism, epilepsy and congenital anomalies.
This was referred to co-occurrence of chromosome 9 long
arm deletion in 9q34.2q34.3 and chromosome 21 long arm
deletion in 21q22.3 (cases #11, #26, #43; Table 1). One can
suggest that a ~179 kbp interval on 9q34.2 and a ~187 kbp
interval on 21q22.3 (deduced on the basis of breakpoint
locations) are both specifically organized at the sequence
level to produce a complex genomic rearrangement causing
intellectual disability with autistic features, speech delay
and facial dismorphisms.CNVs
Cases #22 and #28 exhibited multiple CNVs (more than
three submicroscopic duplications). All the duplications
have been defined to contribute to the severe phenotypic
outcome by bioinformatic analysis. Since similar cases
were not found in the available literature, we have taken
opportunity to designate the condition as meiotic (con-
stitutional) genomic instability.
By bioinformatics, we have identified clinically relevant
CNVs in 15 individuals. These were found to encompass
genes, mutations in which cause developmental delays,
congenital anomalies, intellectual disability, autism, epi-
lepsy, or other neuropsychiatric disorders. Alternatively,
CNV genes, which have not as yet been associated with
a particular disease phenotype, were not necessarily
those associated with benign genome variations. The
bioinformatic analysis has demonstrated a significant
proportion of such genes to be involved in functional
pathways, which, if altered, can be disease-causing (see
Additional file 1).
Comparative cohort characterization
To make a comparative characterization of the cohort, we
have addressed it in a case-by-case manner. Previously un-
reported CNVs, exclusive chromosomal imbalances and
meiotic genome instability were excluded. Case # 1 is the
unique combination of known chromosomal abnormalities
[13,14]. Multiple chromosome abnormalities are extremely
rare and are usually associated with severe phenotypes
(i.e. prenatal mortality) [15,16]. Severe congenital anomal-
ies were eventually observed in this case.
Case #2 is a microdeletion of the chromosome 19 long
arm that is clinically similar to 19q13.11 deletion syn-
drome [17]. Case #3 is a chromosome 20 long arm
microdeletion associated with mild intellectual disability
and facial dysmorphisms. The chromosomal region was
Figure 1 Examples of array CGH graphical overviews. A. Case #8: a deletion of chromosome X short arm and a duplication of chromosome 3
short arm — arr Xp22.33p22.2(2,333,897-9,726,574)x1,3p26.3p22.3(200,000-36,550,871)x3 — due to an unbalanced maternal translocation t(X;3)
(conventional karyotyping was performed after array CGH analysis). B. Case #27: a deletion of chromosome 7 long arm (subtelomeric 7q deletion) —
arr 7q36.2q36.3(152,768,630-158,261,821)x1. C. Case #18: a duplication of chromosome 19 short arm — arr 19p13.3(260,000-4,953,188)x3.
D. Case #20: a deletion of chromosome 10 long arm (subtelomeric 10q deletion) — arr 10q26.2q26.3(128,192,760-134,070,099)x1. E. Case #40:
a duplication of chromosome 5 long arm — arr 5q13.2(68,931,140-72,690,180)x3.
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which demonstrated more severe phenotypes [18].
Ring chromosome 11 (case #4) characterized in the
present study is phenotypically similar to previous cases
[19], exhibiting, however, additional clinical features (aut-
ism), which are attributed to the presence of CNVs. Case
#6 has turned to be a recurrent translocation between
chromosomes 4 and 8 causing the Wolf-Hirschhorn syn-
drome, being, however, more complex as those described
previously [20].
Case #8 was a chromosome imbalance identified in a
distant patient (immediate cytogenetic analysis was not
available). After array CGH, additional further molecularcytogenetic studies and cytogenetic re-evaluation, it was
defined as an unbalanced translocation between short
arms of chromosomes X and 3. Several similar cases
have been described [21,22].
Case #12 is a deletion of chromosome 3 short arm in a
child with Asperger syndrome. Chromosomal abnorma-
lities are occasional in this neurobehavioral disorder.
However, a study has shown positive Asperger syndrome
linkage to 3p21-24 [23].
In case #13, a CNV (duplication) in Xp11.23 was found.
Recently, a duplication of the same chromosomal region
was shown to cause similar phenotype [24]. Case #15
was another chromosome imbalance identified in a distant
Table 1 The Russian cohort of children with intellectual disability with or without autism and congenital anomalies:
clinical information and array CGH results
Case # Age Clinical features Array CGH results (according to ISCN (2013) [11])
1* 10 m (months) Partially similar to the phenotype of 1p36 deletion
and Pallister–Killian syndromes (“reverse phenotyping”,
as defined by Slavotinek, 2008 [12])
47,XXY.arr(X)x2,1p36.32p36.22(4,932,799-9,373,344)
x1,12p13.33p11.1(153,050-33,636,183)x2~4,
2* 1 y (year) Developmental delay, pachygyria, multicystic,
encephalomalacia seizures, obesity, short neck, and
ear dysmorphism
arr 19q13.12p13.2(41,730,447-43,880,848)x1
3* 7 y Mild intellectual disability and facial dysmorphisms arr 20q11.21(29,392,835-32,017,043)x1
4* 8 y Developmental delay, intellectual disability-microcephaly,
single transverse palmar crease, acrosyndactyly,





5 4 y 7 m Developmental delay, intellectual disability, microcephaly,
single transverse palmar crease, clinodactyly, hypotelorism,
short neck, short stature, broad breast
arr(1–22,X)x2
6* 2 y Severe developmental delay, partially similar to the Wolf-
Hirschhorn syndrome phenotype (“reverse phenotyping”,




7 4 y 3 m Intellectual disability, high-arched palate, low-set ears,
facial dysmorphisms
arr(1–22)х2,(XY)x1
8§ 10 y Intellectual disability, developmental delay, facial
dysmorphisms, single transverse palmar crease, pectus




9 1y 8 m Severe developmental delay, seizures, microcephaly,
broad flat face, myopia
arr(1–22,X)x2
10 4y 4 m Mild cognitive delay, optic nerve hypoplasia, strabismus,
upslanting palpebral fissures, epicanthal fold,
hypertrichosis, hypertelorism, broad nasal bridge
arr(1–22)х2,(XY)x1




12* 9 y Autistic disorder (Asperger syndrome), cervical spine
abnormalities, pancreatitis
46,XY,arr 3p22.1p21.32(42,284,371-44,741,252)x1
13 4 y 7 m Speech and cognitive delay, seizures, macrocephaly,




14 4 y Developmental and speech delay, ataxia arr(1–22)х2,(XY)x1
15§ 3 m Developmental and cognitive delay, corpus callosum
agenesis, congenital heart defect, microcephaly,
pulmonary hypoplasia, facial dysmorphisms
arr 10q25.2qter(112,060,103-135,168,517)x3,13q33.3qter
(108,359,829-114,080,000)x1
16 6 y 2 m Mild developmental and cognitive delay, autistic
features, microcephaly, hypertelorism, clinodactyly,
syndactyly, small ears
arr(1–22)х2,(XY)x1




18 7 m Developmental delay, intellectual disability-intrauterine
growth retardation, cryptorchidism, facial dysmorphisms,
camptodactyly, apnea
46,XY.arr 19p13.3(260,000-4,953,188)x3








21 5 y Intellectual disability, speech delay, cognitive delay, autism arr Yq11.223(26,903,388-27,059,018)х2,5q13.2(70,231,
675-70,389,712)х3
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Table 1 The Russian cohort of children with intellectual disability with or without autism and congenital anomalies:
clinical information and array CGH results (Continued)
22 1 y 11m Severe developmental delay and congenital heart





23*,ǂ 4 y Intellectual disability, developmental delay, facial
dysmorphisms, high-arched palate, congenital




24 1 y 9 m Developmental delay, optic nerve hypoplasia 46,XY.arr 16p13.3(3,592,260-3,783,073)х3
25 6 y Intellectual disability, developmental and speech
delay, microcephaly, seizure, partial optic nerve
atrophy, ataxia, muscular hypotonia
arr(1–22,X)x2
26 4 y Intellectual disability, speech delay, developmental
delay, microcephaly, epicanthic fold, broad nasal





27* 4 y 5 m Lumbosacral dysgenesis, microcephaly, hypospadias,
congenital ventricular septal defect, pectus excavatum,
myelocele, small lower jaw, upslanting palpebral fissures,
teeth anomalies, autistic features, mild cognitive delay
46,XY,1qh-.arr 7q36.2q36.3(152,768,630-158,261,821)x1
28 2 y 2 m Intellectual disability, severe developmental and cognitive
delay, microcephaly, seizures, hypertelorism, single





29 1 y 5 m Developmental delay, intellectual disability, downslanting
palpebral fissures, hypertelorism, facial dysmorphisms
arr(1–22,X)x2




31 2 y 5m Intellectual disability and speech delay, short stature,
flat nasal bridge, muscle hypotonia, MRI abnormalities
46,XX,15phqh.arr 1p36.32(2,368,110-2,522,845)x1,4p16.3(752,
795-906,771)x1,20q13.33(60,355,527-60,494,531)x1





33 4 y Speech and cognitive delay, somatomegaly, congenital
heart defect
arr (1–22)х2,(XY)x1
34 7 y Speech delay, syndactyly, deafness, sandal gap, high-arched
palate, congenital heart defect, epiphyseal dysplasia
46,XY,1phqh.arr 9q34.3(137,679,970-137,867,305)x3




36 1y 10 m Developmental and speech delay, trigonocephaly, seizures,
craniostenosis, facial dysmorphisms
arr (1–22)х2,(XY)x1
37 2y 6m Intellectual disability, autistic features, facial dysmorphisms,
single transverse palmar crease
arr (1–22)х2,(XY)x1
38ǂ 4 y 6 m Speech delay, cognitive delay, clinodactyly, hypertelorism 46,XY.arr Xq12(66,858,503-67,027,800)x0




40 9 m Developmental delay, intellectual disability, congenital heart
defect, myopia, facial dysmorphisms
46,XX,1qh-,13pstk+.arr 5q13.2(68,931,140-72,690,180)x3
41 3 y Severe speech and cognitive delay, microcephaly, facial




42 7 y Speech and cognitive delay, high-arched palate, single
transverse palmar crease, small teeth
46,XX,15phqh+.arr 1p36.32(2,368,110-3,076,708)x1,5p15.33
(403,337-1,562,887)x1




44 4 y Intellectual disability, speech delay, neurobehavioral disorder arr 11q23.3(120,091,054-120,251,056)x1,16q21(59,719,829-
59,928,048)x3
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Table 1 The Russian cohort of children with intellectual disability with or without autism and congenital anomalies:
clinical information and array CGH results (Continued)




46 2 y Intellectual disability, speech and cognitive delay,
microcephaly, autistic features, syndactyly
46,XX,1qh-.arr Xp22.31(5,981,359-6,146,376)x1,2q36.1(222,
366,094-222,493,489)x3,10q26.3(135,070,014-135,240,498)x3
47 1 y Developmental and speech delay, congenital heart
defect, congenital lung malformation, syndactyly,
esophageal atresia, cleft palate
46,XY.arr 7q11.23(76,142,331-76,323,858)x3,17q21.31(41,559,
185-41,734,024)x3
48ǂ 4 y Intellectual disability, autism 46,XY, 9phqh.arr Xq28(154,487,912-154,657,923)x0
49ǂ 4 y10 m Intellectual disability, developmental delay, facial











51ǂ 1 y 10 m Developmental and speech delay, facial dysmorphisms 46,ХX.arr Xq28(153,435,103-153,609,374)х1,Xq28(152,731,931-
152,937,571)x1,14q32.33(105,149,438-105,332,624)x1
52ǂ 4 y 6 m Intellectual disability, developmental delay, autism 46,XY,9phqh.arr Yq11.223(23,230,058-25,468,406)x0,1p36.33
(2,120,746-2,270,566)x1,5q13.2(68,931,140-70,516,922)x1










*— confirmed by molecular cytogenetic methods (i.e. FISH); ǂ— confirmed by molecular genetic methods (PCR or QPCR);
§— conventional karyotyping was performed after array CGH analysis;
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tion between long arms of chromosomes 10 and 13 after
cytogenetic re-evaluation.
Chromosomal rearrangements in the chromosome 19
short arm are extremely rare [25]. Case #18 is the largest
ever reported 19p subtelomeric duplication. Case #20 is
a 10q subtelomeric deletion; similar cases were previ-
ously described, but the clinical manifestations are usu-
ally variable and a specific phenotype is not associated
[2]. Case #23 exhibits a number of clinical features of
the Xq28 duplication syndrome [26]; the phenotypic
discrepancies have been attributed to CNVs.
A 7q subtelomeric deletion was identified in case #27.
Despite of characteristic clinical features (lumbosacral
dysgenesis) [27], it was almost impossible to suggest this
chromosomal imbalance prior to array CGH. Cases #30
and #52 have demonstrated chromosome Y long arm
deletions. Similar cases were detected during a case–
control array CGH study applied to prenatal diagnosis,
but the outcome has remained uncertain [28].
Cases #32, #32, #49 and #50 were found to exhibit Xq28
deletions. A retrospective clinical analysis has shown that
Rett-syndrome-like phenotypic manifestations do present
in these girls. It is not surprising inasmuch as two cases
of these deletions involved MECP2. Interestingly, there
have been several attempts to characterize chromosomalrearrangements by molecular cytognetic techniques in
Rett syndrome cohorts without apparent evidence for the
presence of genomic variations involvingMECP2 [29-31].
In case #39, a CNV within RB1 gene was found and
the phenotype was similar to interstitial 13q microdele-
tions [32]. An Xq28 CNV (involving RAB39B gene) was
found in a child with intellectual disability and autism
(case #48). It is to note, that RAB39B mutations cause
X-linked mental retardation associated with autism, epi-
lepsy, and macrocephaly [33].
Finally, case #53 was the third chromosome imbalance
identified in a distant patient. Subsequently, it turned
out to be an unbalanced translocation between the long
arm of chromosome 1and the short arm of chromosome
16 after fluorescence in situ hybridization (FISH) and
cytogenetic evaluation. Comparing the phenotype with
previous reports [34,35], we concluded that the clinical
features in this case has similarities as with trisomy 16p
as with 1q subtelomeric deletions.
Discussion
The present study has again provided evidence that array
CGH is a powerful technique for uncovering chromo-
somal imbalances and genomic rearrangements. Previous
case–control studies (reviewed in [2,5,8-10]) have demon-
strated the high diagnostic yield of microarray-based
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based technologies for detecting genomic imbalances in
clinical populations. However, the detection rate (over 50%)
seems to be significantly higher in our study comparing
to the previous ones (5-20%) [1-10]. Since the incidence
of genomic rearrangements detectable by array CGH is
strongly influenced by selection bias of patients, the
reported detection rate is likely to be higher inasmuch as
our criteria were much more discriminating than previously
applied (i.e. evaluating the diagnostic yield in “idiopathic”
cohorts). Thus, we do not insist that the reported detection
rate is characteristic for an array CGH control cohort study.
Still, it can be expected that an application of array CGH to
highly selected patients is able to demonstrate an impres-
sive detection rate of structural genome variations.
It is generally recognized that numerical and structural
chromosome abnormalities are the major genetic causes of
postnatal morbidity including a wide spectrum of diseases
associated with brain dysfunction [13,14]. However, before
the implementation of molecular cytogenetic techniques
(array-CGH- and FISH-based technologies), the contribu-
tion of genome/chromosome imbalances to the etiology
was usually considered as less than 5% [4,7,9,10,14]. Array
CGH data are not only relevant to molecular diagnosis,
but also to the discovery of genetic (genomic) mechanisms
of brain diseases [1-10,14]. Here, we were also able to
demonstrate similar etiologic yield. In this instance, the
present gene list (Additional file 1) possesses implications
for the delineation of the cellular and molecular basis of
disease and requires further bioinformatic analyses.
Although array CGH is a highly efficient technique for
definition of chromosome/genome rearrangements in
clinical populations, it has limitations. For example, it
does not properly reflect somatic mosaicism [36-38],
which is commonly associated with postnatal morbidity,
including brain diseases [37-41]. The pathogenic value
of submicroscopic genomic variations can be a matter of
conjecture [2-10]. Therefore, array-CGH-based methods
have to be combined with molecular cytogenetic, post-
genomic and bioinformatic technologies for detailed
studies of disease mechanisms. Nonetheless, array CGH
assays are mandatory for such studies.
Apart from numerical constitutional and mosaic chromo-
some abnormalities (case #1) the genomic rearrangements
were found to affect 1247 genes in total. Details about these
genes are provided in Additional file 1. Accordingly, we
speculate that the majority of these genes can be mutated
in intellectual disability, autism or epilepsy. The latter can
be easily seen if one addresses a molecular/clinical genetic
database (i.e. OMIM — http://www.omim.org/; referenced
in Additional file 1). Moreover, combinations of deletions/
duplications affecting these genomic loci produce a “CNV
burden”, which can be considered a possible genetic
cause of postnatal morbidity. On the other hand,it is to recognize that a significantly lesser part of them
are true candidates for the aforementioned neuropsychi-
atric diseases.
Array CGH does improve the etiologic yield across the
spectrum of patients with neuropsychiatric disorders and
congenital anomalies. This improvement has been
achieved by systematic cohort studies. The available litera-
ture indicates that we report on the first comprehensive
array CGH analysis of a Russian cohort of children with
intellectual disability, autism, epilepsy and congenital
anomalies. The efficiency of the approach (array CGH +
bioinformatic strategy) allows us to expand the cohort. To
this end, it is necessary again to point out that patient pre-
selection provided for the discovery of up to 31% of previ-
ously unreported genomic rearrangements among detect-
able imbalances. In other words, this report describes
novel disease genes uncovered in a relatively small cohort.
Hence, our next study of the expanded cohort would cer-
tainly lead to discovering new candidate genes and shared
molecular pathways of intellectual disability, autism, epi-
lepsy and related neuropsychiatric disorders.
Methods
Patients
From November 2007 to May 2012, 2426 patients referred
to our molecular cytogenetic facilities. All the patients
were studied by conventional karyotyping (G- and C-
banding analyses) at a G-banding resolution of about 550
bands according to ISCN (2013) [11]. The ages varied
between 1 month and 18 years. Fifty four patients were
highly selected to be the first participants of the Russian
cohort of children with intellectual disability, autism, epi-
lepsy and congenital anomalies based on clinical and cyto-
genetic/molecular cytogenetic data. Molecular cytogenetic
techniques (FISH-based methods) were used to exclude
cases of cytogenetically visible chromosome abnormalities
(confirmation by molecular cytogenetic techniques) and
microdeletion/microduplication syndromes. FISH was also
used in cases of chromosomal mosaicism (especially, those
children who were the participants of the Russian autism
cohort and were shown to exhibit chromosomal mosai-
cism; for more details see [42-44]). Such cases have been
excluded. Subtelomeric chromosomal rearrangements
(commonly detected in children with intellectual disability
[2]), addressed by a previously reported FISH analysis with
original DNA probes [45], were excluded from the cohort,
as well. Cases positive for mutations causing fragile X and
Rett syndrome (common causes of intellectual disability
and autistic features in children) addressed by molecular
genetic techniques (PCR/QPCR and direct sequencing of
the MECP2 gene) were ruled out. For three distant
patients, immediate cytogenetic analysis was not available
due to natural (distance) limitations. As a result, they were
included in the cohort. Two cytogenetically positive cases
Figure 2 The incidence of chromosome imbalances (subdivided to cytogenetically detectable and undetectable abnormalities),
CNVs and meiotic genome instability in the Russian cohort of children with intellectual disability with or without autism and
congenital anomalies. Cytogenetically detectable cases were patients, who were cytogenetically re-evaluated. This has yielded the correct
diagnosis (see also Table 1).
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chromosome 11) exhibiting extremely atypical phenotypic
manifestations were also included. Written informed con-
sent was obtained from the patients’ parents.
Array CGH
Array CGH was performed with the customized human
genomic microarrays (slightly modified Constitutional
ChipW4.0) containing about 5200 human BAC clones
(Human BAC Array-System, Perkin Elmer, USA). The reso-
lution of the whole genome scan was estimated to be 0.3-1
Mb. The microarrays contain more than 1200 BAC probes
for the majority of "new" and "old" microdeletion/microdu-
plication syndromes (for the description see [2,3,5,7]), about
900 BAC probes — subtelomeric regions, about 100 BAC
probes — percintromeric chromosomal regions, 621 BAC
probes — chromosome X, and about 2000 BAC probes —
remaining euchromatic chromosomal regions, allowing the
whole genome to be scanned with a resolution of at least 1
Mb. DNA labelling, hybridization, detection and data ana-
lysis was made according to previously described protocols
[46] and to manufacturers’ instructions.
Confirmation methods
Molecular cytogenetic (FISH) and molecular genetic
(PCR/QPCR) methods were used for the confirmation of
genomic rearrangements in a number of cases (n=18).
FISH with DNA probes from our original collection
(probes for heterochromatic and euchromatic (repetitive
and unique) chromosomal regions) was performed as
described previously [45,47,48]. The confirmation was
performed in nine cases (Table 1).PCR (or QPCR) was essentially used to confirm the
rearrangements affecting chromosomes X and Y (i.e.
deletions of AR in Xq12, MECP2 in Xq28, and DAZ loci
in Yq11.223). The confirmation was performed in nine
cases (Table 1).
Bioinformatics
In silico (bioinformatic) analyses were performed in part
according to Iourov et al., 2009, 2010 [49,50]. To deter-
mine the pathogenic value of CNVs, genotype-phenotype
correlations and CNV or gene prioritization were done by
a series of evaluations using clinical/cytogenetic and gen-
omic variation databases as well as bioinformatic tools for
genome, epigenome and pathway analysis.
Genotype-phenotype correlations and pathogenic value
of CNVs were estimated using DECIPHER (database of
unbalanced chromosome aberrations) — http://decipher.
sanger.ac.uk/, OMIM (online Mendelian inheritance in
Man) — http://www.omim.org/, The Phenotype-Genotype
Integrator (PheGenI) — http://www.ncbi.nlm.nih.gov/gap/
PheGenI, SFARI Gene/AutDB (web-based searchable data-
base for autism research) — http://www.mindspec.org/
autdb.html, and a Catalog of Published Genome-Wide
Association Studies (NHGRI) — http://www.genome.gov/
gwastudies/.
CNVs were also compared to the Database of Genomic
Variants (http://dgvbeta.tcag.ca/dgv/app/home?ref=GRCh37/
hg19). The prioritization of CNVs and genes was done using
BioGPS (a gene annotation and expression) — http://biogps.
org, Ensembl Genome Browser — http://www.ensembl.org/
index.html, KEGG (Kyoto Encyclopedia of Genes and
Genomes) — http://www.genome.jp/kegg/, NCBI BioSystems
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http://www.molecularcytogenetics.org/content/5/1/46Database — http://www.ncbi.nlm.nih.gov/biosystems, NCBI
Gene — http://www.ncbi.nlm.nih.gov/gene/, NCBI Build
37.1/NCBI Map Viewer — http://www.ncbi.nlm.nih.gov/pro-
jects/mapview/map_search.cgi?taxid=9606, REACTOME —
www.reactome.org/, Pathway Commons — http://www.
pathwaycommons.org/pc/, and UCSC Genome Browser —
http://genome.ucsc.edu/.
Endnote
aThe data reported in the present article have been pre-
sented in part at the European Human Genetics Confe-
rence 2011, Amsterdam, The Netherlands, May 28–31,
2011.Additional file
Additional file 1: Genes affected by chromosome imbalances and
CNVs.
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